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Materials and Methods 
NMR spectra were recorded using Varian Mercury 300, Inova 500, and VNMRS 
400 MHz NMR spectrometers.  NMR chemical shifts are reported in parts per million 
(ppm) downfield from tetramethylsilane (TMS) with reference to internal solvent for 1H 
and 13C nuclei.  Spectra are reported as follows: chemical shift (δ ppm), multiplicity, 
coupling constant (Hz), and integration. Gas chromatography data was obtained using an 
Agilent 6850 FID gas chromatograph equipped with a 0.25 mm x 30 m x 0.25um film 
thickness DB-Wax Polyethylene Glycol capillary column (J&W Scientific). High-
resolution mass spectroscopy (FAB) was completed at the California Institute of 
Technology Mass Spectrometry Facility. 
Catalysts 1-10 were obtained from Materia, Inc. Unless otherwise indicated, all 
compounds were purchased from Aldrich or Fisher and used as obtained. The compounds 
11,1 12,1 14,2 16-18,3,4 23-245 have been described previously and were prepared 
according to literature procedures or identified by comparison of their spectroscopic data. 
The initial screening of the catalysts, in ring-closing metathesis (RCM) via 1H NMR was 
conducted according to literature procedures.6 
 
Low Catalyst Loading Assay. 
Experiments on the RCM of 11, 13, 15, 17, 19, 21, 23, 25, and 27 using the 
catalysts described were conducted using a SymyxTM Technologies Core Module (Santa 
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Clara, CA) housed in a Braun nitrogen-filled glovebox and equipped with Julabo LH45 
and LH85 temperature-control units for separate positions of the robot tabletop.   
Up to 576 reactions (6 x 96 well plates) could be performed simultaneously in 1 
mL vials by an Epoch software-based protocol as follows. To prepare catalyst stock 
solutions (0.25 mM), 20 mL glass scintillation vials were charged with catalyst (5 µmole) 
and diluted to 20.0 mL total volume in THF.  Catalyst solutions, 6 to 800 µL depending 
on desired final catalyst loading, were transferred to reaction vials and solvent was 
removed via centrifugal evaporation.  The catalysts were preheated to the desired 
temperature using the LH45 unit, and stirring was started. Substrates (0.1 mmol), 
containing dodecane (0.025 mmol) as an internal standard, were dispensed 
simultaneously to 4 reactions at a time using one arm of the robot equipped with a 4-
needle assembly.  Immediately following substrate addition, solvent was added to reach 
the desired reaction molarity.  All reactions were quenched by injection of 0.1 mL 5% v/v 
ethyl vinyl ether in toluene. 
 
GC Data Analysis. 
Samples were analyzed by gas chromatography with dodecane as an internal 
standard, measured the change in substrate and product over time.  
Relevant instrument conditions: Inlet temperature = 150 ºC; detector temperature 
= 250 ºC; hydrogen flow = 32mL/min; air flow = 400 mL/min; constant col + makeup 
flow = 30 mL/min.  
GC Method: 75 ºC for 4 minutes, followed by a temperature increase of 25 
ºC/min to 160 ºC, and a subsequent isothermal period at 160 ºC for between 2-8 minutes, 
depending on substrate mass. (total run time = 10-16 minutes).  Method for 27 and 28 
began at 80 ºC. 
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Table 1.  GC Retention times (Rt) of Compounds 11-28.                          
Compound GC Rt (min)
11 7.046
12 8.374
13 7.824
14 8.897
15 8.285
16 9.485
17 7.376
18 9.152
19 8.099
20 9.628
21 8.866
22 10.480
23 7.529
24 10.413
25 8.905
26 10.986
27 7.459
28 10.242
 
 
Experimental 
General procedure for the synthesis of N-Boc-1-(3-butenyl)allylamine (13), N-
Boc-1-(3-butenyl)methallylamine (19), and N-Boc-1-(3-methyl-3-
butenyl)methallylamine (25) RCM substrates: 
N
Boc
BocHN
R
Br
R'
R
R'
13; R=R'=H
19; R=H, R'=Me
25; R=R'=Me
 
The Boc-protected olefin (1 eq) was added at room temperature to a suspension of 
60% NaH (1.5 eq) mineral oil dispersion in 150 mL of DMF. The slurry was stirred for 
2h followed by addition of the allylbromide (1.3 eq) at 0ºC. The reactions were 
monitored by gas chromatography until all of the Boc-protected olefin was consumed. 
The reaction was quenched with MeOH and water followed by extraction with hexanes 
(3 x 60mL). The organic phases were combined and dried over MgSO4; the organic 
solvent was removed to give light yellow oil. The crude product was purified by column 
chromatography on silica and eluted with 0-4% EtOAc in hexanes. The pure products 
(97% by GC) were clear colorless oils and 60-70% yields were obtained.  
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General procedure for the synthesis of N-Boc-1-(3-dibutenyl)amine (15), N-Boc-1-(3-
butenyl)-1-(3-methyl-3-butenyl)amine (21), N-Boc-1-(3-methyl-3-dibutenyl)amine (27) 
RCM substrates:   
NH3Cl
R
R'
15; R=R'=H
21; R=H, R'=Me
27; R=R'=Me
X
X = -Br or -OTs
N
Boc
R R'
Boc2O, Et3N
 
 The 4-bromo-1-butene or 4-tosylic-1-butene (1 eq), butenylamine hydrochloride 
(1.1 eq), and NaHCO3 (1.1 eq) were suspended in 150 mL of THF and heated to 60˚C for 
2 days. After cooling to room temperature, triethylamine (2.8 eq) was added followed by 
addition of di-tert-butyl dicarbonate (1.1 eq) over 15 minutes maintaining a constant gas 
evolution. The suspension was stirred for 90 minutes and the solids were removed by 
filtration. The filtrate was concentrated, re-dissolved in 50 mL of MeOH, and 5 mL of 
1M NaOH (aq) was added. This mixture was stirred at room temperature for 16h and 
formed a cream-colored slurry.  The solids were removed by filtration, the filtrate was 
concentrated, and the residue partitioned between Et2O and saturated NaHCO3 (aq). The 
organic phase was washed with water and brine, dried over Na2SO4, filtered, and 
concentrated to yield a brown oil. The crude product was purified by column 
chromatography on silica and eluted with 0-4% EtOAc in hexanes. The pure products 
were clear pale yellow oils and 40-50% yields were obtained.  
 
N-Boc-1-(3-butenyl)allylamine (13) 
1H NMR (400 MHz, CDCl3): δ 5.75 (m, 2H), 4.97-5.12 (m, 4H), 3.80 (br, 2H), 
3.21 (br, 2H), 2.25 (br, 2H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 
155.54, 135.66, 134.47, 116.51, 79.49, 49.96 / 49.65 (rotamers), 46.32, 33.16 / 
32.86 (rotamers), 28.51. HRMS Calc’d for C13H23O2N: 212.1650. Found: 
212.1640. 
 
 
 
N
Boc
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N-Boc-1-(3-dibutenyl)amine (15) 
1H NMR (400 MHz, CDCl3): δ 5.75 (m, 2H), 5.07 (m, 1H), 5.02 (m, 2H), 
4.99 (m, 1H), 3.22 (br, 4H), 2.26 (br, 4H), 1.44 (s, 9H). 13C NMR (75 MHz, 
CDCl3): δ 155.58, 135.69, 116.54, 79.36, 47.09, 33.49 / 32.94 (rotamers), 
28.57. HRMS Calc’d for C14H25O2N: 226.1807. Found: 226.1797. 
 
N-Boc-1-(3-butenyl)methallylamine (19) 
1H NMR (400 MHz, CDCl3): δ 5.76 (m, 1H), 5.06 (d, 1H, J3 = 32 Hz), 5.02 
(d, 1H, J2 = 4 Hz), 4.82 (s, 1H), 4.76 (s, 1H), 3.75 (br, 2H), 3.20 (br, 2H), 
2.26 (br, 2H), 1.67 (s, 3H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 
140.17, 134.25, 115.50, 110.61, 79.43, 53.67 / 53.11 (rotamers), 46.83, 34.16 / 33.61 
(rotamers), 29.76, 21.46. HRMS Calc’d for C13H23O2N: 226.1807. Found: 226.1807. 
 
1-(tert-Butoxycarbonyl)-3-methyl-1,2,5,6-tetrahydropyridine (20) 
1H NMR (400 MHz, CDCl3): δ 5.50 (br, 1H), 3.72 (br, 2H), 3.42 (t, 2H, J3 = 6 
Hz), 2.06 (s, 2H), 1.66 (s, 1H), 1.46 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 
155.05, 119.83, 79.51, 47.30 / 46.05 (rotamers), 40.86 / 39.55 (rotamers), 
28.62, 28.41, 20.60. HRMS Calc’d for C11H18O2N: 196.1338. Found: 196.1333.  
 
N-Boc-1-(3-butenyl)-1-(3-methyl-3-butenyl)amine (21) 
1H NMR (400 MHz, CDCl3): δ 5.76 (m, 1H), 5.07 (d, 1H, J3 = 34 Hz), 5.02 
(d, 1H, J2 = 5Hz), 4.74 (s, 1H), 4.68 (s, 1H), 3.23 (br, 4H), 2.18-2.27 (br m, 
4H), 1.74 (s, 3H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 153.51, 
134.19, 115.51, 111.01, 110.70, 79.28, 46.98 / 47.23 (rotamers), 47.60 / 
47.85 (rotamers), 37.44 / 38.10 (rotamers), 34.06 / 34.59 (rotamers), 29.79, 23.99. HRMS 
Calc’d for C14H25O2N: 240.1964. Found: 240.1974. 
 
1-(tert-Butoxycarbonyl)-4-methyl-2,3,6,7-tetrahydroazepine (22) 
1H NMR (400 MHz, CDCl3): δ 5.46 (m, 1H), 3.44 (br, 4H), 2.20 (br, 4H), 
1.70 (br, 3H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 155.33, 123.50 / 
123.17 (rotamers), 79.22, 47.18 / 46.44 (rotamers), 45.333 / 44.61 (rotamers), 
N
Boc
N
Boc
N
Boc
N
Boc
N
Boc
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35.32 / 35.11 (rotamers), 28.62, 26.65. HRMS Calc’d for C12H21O2N: 211.1572. Found: 
211.1564. 
 
N-Boc-1-(3-methyl-3-butenyl)methallylamine (25) 
1H NMR (400 MHz, CDCl3): δ 4.83 (s, 1H), 4.76 (s, 1H), 4.74 (s, 1H), 
4.74 (s, 1H), 4.68 (s, 1H), 3.75 (d, 2H, rotamers), 3.24 (d, 2H, rotamers), 
2.20 (br, 2H), 1.73 (s, 3H), 1.67 (s, 3H), 1.45 (br s, 9H). 13C NMR (75 
MHz, CDCl3): δ 140.22, 111.04, 110.71, 79.41, 53.54 / 52.93 (rotamers), 
46.11, 37.67 / 37.00 (rotamers), 29.76, 23.97, 21.44. HRMS Calc’d for C14H25O2N: 
240.1964. Found: 240.1963. 
 
1-(tert-Butoxycarbonyl)-3,4-dimethyl-1,2,5,6-tetrahydropyridine (26) 
1H NMR (400 MHz, CDCl3): δ 3.68 (br, 2H), 3.43 (t, 2H, J3 = 5.6 Hz), 1.99 
(s, 2H), 1.63 (s, 3H), 1.59 (s, 3H), 1.45 (s, 9H). 13C NMR (75 MHz, CDCl3): 
δ 154.95, 79.30, 47.80 (rotamers), 41.47 / 40.16 (rotamers), 31.26, 28.60, 
18.77, 16.13. Calc’d for C12H21O2N: 212.1572. Found: 212.1569. 
 
N-Boc-1-(3-methyl-3-dibutenyl)amine (27) 
1H NMR (400 MHz, CDCl3): δ 4.74 (s, 2H), 4.68 (s, 2H), 3.25 (br, 4H), 
2.21 (br, 4H), 1.74 (s, 6H), 1.44 (s, 9H). 13C NMR (75 MHz, CDCl3): δ 
153.44, 141.62, 111.02, 110.74, 79.26, 47.08 / 46.77 (rotamers), 38.13 / 
37.47 (rotamers), 29.81, 24.00. HRMS Calc’d for C15H27O2N: 254.2120. 
Found: 254.2121. 
 
1-(tert-Butoxycarbonyl)-4,5-dimethyl-2,3,6,7-tetrahydroazepine (28) 
1H NMR (400 MHz, CDCl3): δ 3.29 (br, 4H), 2.24 (br, 4H), 1.67 (s, 6H), 1.46 
(s, 9H). 13C NMR (75 MHz, CDCl3): δ 155.62, 79.35, 45.22 / 44.41 
(rotamers), 37.10 / 36.43 (rotamers), .35.32 / 35.11 (rotamers), 28.62, 21.76. 
HRMS Calc’d for C13H24O2N: 226.1807. Found: 226.1812. 
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13, 13C, CDCl3 
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25, 1H, CDCl3  
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27, 1H, CDCl3  
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